Astrocytopathy is associated with CA1 synaptic dysfunction in a mouse model of Down syndrome

Fernández-Blanco, Álvaro; González-Arias, Candela; Sierra, Cesar; Zamora Moratalla, Alfonsa; Perea, Gertrudis; Dierssen, Mara

doi:http://dx.doi.org/10.3390/cells14171332

Astrocytopathy is associated with CA1 synaptic dysfunction in a mouse model of Down syndrome

License

Citation

Fernández-Blanco Á, González-Arias C, Sierra C, Zamora-Moratalla A, Perea G, Dierssen M. Astrocytopathy is associated with CA1 synaptic dysfunction in a mouse model of Down syndrome. Cells. 2025;14(17):1332. DOI: 10.3390/cells14171332

Abstract

Brain pathophysiology in Down syndrome (DS), the most common genetic cause of intellectual disability, has traditionally been considered a consequence of neuronal dysfunction. However, although it is well documented that astrocytes play a critical role in brain homeostasis, synaptic regulation, and neuronal support, and their malfunction has been associated with the onset and progression of different neurological disorders, only a few studies have addressed whether astrocyte dysfunction can contribute to the DS pathophysiology. Astrocytes are increased in number and size, and show increased levels of expression of astroglial markers like S100ß and GFAP. In this study, we detected a region-specific increase in astrocyte population in CA1 and, to a lesser extent, in the dentate gyrus. Single-nucleus transcriptomic profiling identified markers associated with reactive astroglia, synaptic transmission, and neuroinflammation in trisomic astrocytes. Functional analysis revealed abnormal Ca2+ oscillations in trisomic astrocytes and impaired astrocyte-to-neuron communication in CA1, the most affected subregion, leading to astrocyte-mediated excitatory synaptic depression. Our findings demonstrate that astrocytes play an active and critical role in the pathophysiology of DS, not only as reactive responders to neuronal injury but as key contributors to the disease process itself. This astrocytic dysfunction presents a region-specific distribution within the hippocampus, suggesting localized vulnerability and complex glial involvement in DS-related neuropathology.